P1‐043: Circulating and Intrathecal Mirnas as Potential Biomarkers for Alzheimer's Disease
Year: 2014
Type: article
Study design: Observational Study
Abstract: Circulating micro (mi) RNAs have been reported as promising biomarkers with great accuracy for neurodegenerative disorders and processes affecting the central nervous system, particularly in aging, Parkinson's disease and Multiple Sclerosis. Aim of this study is to identify specific circulating miRNAs in serum as possible biomarkers for Alzheimer's disease (AD). A specific PCR array containing 84 common miRNAs was used to screen miRNA serum levels in 7 patients with AD and 6 Non-Inflammatory Neurological Controls (NINDCs). Best hits were first validated by real time PCR in an independent cohort consisting of 15 serum samples from AD patients and 12 NINDCs, comparing them also to 10 subjects affected by frontotemporal lobar degeneration (FTLD) and 8 Inflammatory Neurological Controls (INDCs). Finally, the same analysis was conducted also in samples of cerebrospinal fluid (CSF). Statistically significant decreased levels of miR-125b, miR-223, miR-23a and miR-26b were observed in AD patients compared to NINDCs (-5.5, -4.5, -5.0 and -6.3 fold regulation over NINDCs respectively, p<0.050). MiR-125b, miR-223 and miR-26b were then validated both in serum and CSF (P<0.050), while miR-23a failed to be replicated in CSF. Moreover, miR-223 was also found down-regulated both in serum and CSF from FTLD patients (p<0.050). These findings suggest a potential use of circulating miRNAs, along with other markers, as non-invasive, relatively inexpensive and peripheral biomarkers for AD diagnosis.
Source: Alzheimer s & Dementia
Institution: University of Milan
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: Alzheimer's disease, circulating microRNAs
Open Access status: green
OpenAlex ID: W2000593287
